References

REDERENCES 1. Pereira AC, Pérez de Val B, Cunha M V. Phylogenetic analysis of Mycobacterium caprae highlights past and present epidemiological links at the Iberian Peninsula scale. Microbes Infect [Internet]. 2025 Feb 1 [cited 2025 Dec 2];27(2). Available from: https://www.sciencedirect.com/science/article/abs/pii/S1286457924001473 2. Hugh BT, Sim EM, Crighton T, Sintchenko V. Emergence of Mycobacterium orygis: novel insights into zoonotic reservoirs and genomic epidemiology. Front Public Health [Internet]. 2025 Mar 19;13:1568194. Available from: https://www.frontiersin.org/journals/publichealth/articles/10.3389/fpubh.2025.1568194/full 3. Olea-Popelka F, Muwonge A, Perera A, Dean AS, Mumford E, Erlacher-Vindel E, et al. Zoonotic tuberculosis in human beings caused by Mycobacterium bovis —a call for action. Lancet Infect Dis [Internet]. 2017 Jan [cited 2019 Aug 28];17(1):e21–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27697390 4. Napp S, Allepuz a, Mercader I, Nofrarías M, López-Soria S, Domingo M, et al. Evidence of goats acting as domestic reservoirs of bovine tuberculosis. Vet Rec [Internet]. 2013;172(25):663. Available from: https://bvajournals.onlinelibrary.wiley.com/doi/10.1136/vr.101347 5. Ciaravino G, Vidal E, Cortey M, Martín M, Sanz A, Mercader I, et al. Phylogenetic relationships investigation of Mycobacterium caprae strains from sympatric wild boar and goats based on whole genome sequencing. Transbound Emerg Dis [Internet]. 2021 May 1 [cited 2021 Dec 22];68(3):1476–86. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/tbed.13816 6. Martínez-Lirola M, Herranz M, Serrano SB, Rodríguez-Grande C, Inarra ED, GarridoCárdenas JA, et al. A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022. Euro Surveill [Internet]. 2023 Mar 1 [cited 2024 Sep 20];28(12). Available from: https://pubmed.ncbi.nlm.nih.gov/36951787/ 7. Pérez de Val B, Vidal E, Stuber T, Sáez JL, Tórtola MT. Zoonotic tuberculosis in Catalonia, Spain: Phylogenetic insights into Mycobacterium bovis and M. caprae transmission at the human-livestock interface. One Health [Internet]. 2025 Jun 1 [cited 2025 Feb 17];20:100993. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352771425000291 8. Waters WR, Palmer M V, Buddle BM, Vordermeier HM. Bovine tuberculosis vaccine research: Historical perspectives and recent advances. Vaccine [Internet]. 2012;30(16):2611–22. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0264410X12001831 9. Pérez De Val B, Villarreal-Ramos B, Nofrarías M, López-Soria S, Romera N, Singh M, et al. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis. Clin Vaccine Immunol [Internet]. 2012;19(9). Available from: https://journals.asm.org/doi/10.1128/cvi.00275-12 10. Srinivasan S, Jones G, Veerasami M, Steinbach S, Holder T, Zewude A, et al. A defined antigen skin test for the diagnosis of bovine tuberculosis. Sci Adv [Internet]. 2019 Jul 17 [cited 2019 Jul 23];5(7):eaax4899. Available from: http://advances.sciencemag.org/lookup/doi/10.1126/sciadv.aax4899 11. Jones GJ, Konold T, Hurley S, Holder T, Steinbach S, Coad M, et al. Test performance data demonstrates utility of a cattle DIVA skin test reagent (DST-F) compatible with BCG vaccination. Sci Rep [Internet]. 2022 Dec 1 [cited 2023 Jan 18];12(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9283413/ 12. Figl J, Köhler H, Wedlich N, Liebler-Tenorio EM, Grode L, Parzmair G, et al. Safety and Immunogenicity of Recombinant Bacille Calmette-Guérin Strain VPM1002 and Its Derivatives in a Goat Model. Int J Mol Sci [Internet]. 2023 Mar 1 [cited 2024 May 8];24(6):5509. Available from: https://www.mdpi.com/1422-0067/24/6/5509/htm 13. Bezos J, Casal C, Álvarez J, Roy A, Romero B, Rodríguez-Bertos A, et al. Evaluation of the Mycobacterium tuberculosis SO2 vaccine using a natural tuberculosis infection model in goats. Vet J [Internet]. 2017 May [cited 2019 Feb 12];223:60–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1090023317300849 14. Roy A, Tomé I, Romero B, Lorente-Leal V, Infantes-Lorenzo JA, Domínguez M, et al. Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis. Vet Res [Internet]. 2019 Dec 15 [cited 2019 Oct 17];50(1):82. Available from: https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-019-0702-7 15. Pérez De Val B, Vidal E, Villarreal-Ramos B, Gilbert SC, Andaluz A, Moll X, et al. A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression. PLoS One [Internet]. 2013;8(11). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081317 16. Arrieta-Villegas C, Allepuz A, Grasa M, Martín M, Cervera Z, Mercader I, et al. Longterm efficacy of BCG vaccination in goat herds with a high prevalence of tuberculosis. Sci Rep [Internet]. 2020;10(1):1–12. Available from: https://doi.org/10.1038/s41598-02077334-1 17. Fromsa A, Willgert K, Srinivasan S, Mekonnen G, Bedada W, Gumi B, et al. BCG vaccination reduces bovine tuberculosis transmission, improving prospects for elimination. Science (1979) [Internet]. 2024 Mar 29 [cited 2025 Apr 29];383(6690):1433–41. Available from: https://www.science.org/doi/10.1126/science.adl3962 18. Arrieta-Villegas C, Perálvarez T, Vidal E, Puighibet Z, Moll X, Canturri A, et al. Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats. Rawkins A, editor. PLoS One [Internet]. 2018 May 9 [cited 2018 Jun 25];13(5):e0196948. Available from: http://dx.plos.org/10.1371/journal.pone.0196948 19. Melgarejo C, Planas C, Cobos A, Arrieta-Villegas C, Sevilla IA, Bezos J, et al. A proof-ofconcept study to investigate the efficacy of heat-inactivated autovaccines in Mycobacterium caprae experimentally challenged goats. Sci Rep [Internet]. 2022 Dec 22;12(1):22132. Available from: https://www.nature.com/articles/s41598-022-26683-0 20. Fernández-Veiga L, Fuertes M, Geijo M V., Elguezabal N, Serrano-Mestre JL, VázquezIniesta L, et al. Protection and diagnostic interference induced by heat-inactivated, phageinactivated and live vaccine prototypes against animal tuberculosis. Front Vet Sci [Internet]. 2025 Jul 21;12:1620497. Available from: https://www.frontiersin.org/journals/veterinaryscience/articles/10.3389/fvets.2025.1620497/full 21. Cuenca-Lara P, Blay-Benach M, Cervera Z, Melgarejo C, Moraleda J, Sevilla IA, et al. Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens. Front Vet Sci [Internet]. 2025 Jan 15;11:1524461. Available from: https://www.frontiersin.org/journals/veterinaryscience/articles/10.3389/fvets.2024.1524461/full 22. Frota CC, Hunt DM, Buxton RS, Rickman L, Hinds J, Kremer K, et al. Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans. Microbiology (N Y) [Internet]. 2004 May 1 [cited 2025 Nov 27];150(5):1519–27. Available from: https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.26660-0 23. Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, et al. PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, d…. BMJ Open [Internet]. 2024 Aug 31 [cited 2025 Nov 27];14(8). Available from: https://pubmed.ncbi.nlm.nih.gov/39645271/ 24. Cardona P, Marzo-Escartín E, Tapia G, Díaz J, García V, Varela I, et al. Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice. Front Microbiol [Internet]. 2016 [cited 2025 Nov 27];6(JAN). Available from: https://pubmed.ncbi.nlm.nih.gov/26779140/ 25. de Homdedeu M, Sanchez-Moral L, Violán C, Ràfols N, Ouchi D, Martín B, et al. Mycobacterium manresensis induces trained immunity in vitro. iScience [Internet]. 2023 Jun 16 [cited 2023 Jun 8];26(6):106873. Available from: http://www.cell.com/article/S2589004223009501/fulltext 26. Lavelle EC, Ward RW. Mucosal vaccines — fortifying the frontiers. Nature Reviews Immunology 2021 22:4 [Internet]. 2021 Jul 26 [cited 2025 Dec 2];22(4):236–50. Available from: https://www.nature.com/articles/s41577-021-00583-2 27. Bull NC, Stylianou E, Kaveh DA, Pinpathomrat N, Pasricha J, Harrington-Kandt R, et al. Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1 + KLRG1 − CD4 + T cells. Mucosal Immunol [Internet]. 2019 Mar 1 [cited 2025 Dec 2];12(2):555–64. Available from: https://pubmed.ncbi.nlm.nih.gov/30446726/ 28. Cuenca-Lara P, Blay-Benach M, Cervera Z, Moraleda J, Sevilla IA, Garrido JM, et al. Intranasal BCG vaccination induces systemic and pulmonary mucosal immune responses against tuberculosis in a goat model. Front Immunol. 2025;In press. 29. Koeken VACM, Verrall AJ, Netea MG, Hill PC, van Crevel R. Trained innate immunity and resistance to Mycobacterium tuberculosis infection. Clin Microbiol Infect [Internet]. 2019 Dec 1 [cited 2025 Nov 25];25(12):1468–72. Available from: https://pubmed.ncbi.nlm.nih.gov/30807849/ 30. Guerra-Maupome M, Vang DX, McGill JL. Aerosol vaccination with Bacille CalmetteGuerin induces a trained innate immune phenotype in calves. PLoS One [Internet]. 2019 Feb 1;14(2). Available from: https://journals.plos.org/plosone/article/figures?id=10.1371/journal.pone.0212751 31. Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE, et al. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol [Internet]. 2024 Dec 9;15:1427559. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1427559/fu ll 32. Korb VC, Chuturgoon AA, Moodley D. Mycobacterium tuberculosis: Manipulator of Protective Immunity. International Journal of Molecular Sciences 2016, Vol 17, Page 131 [Internet]. 2016 Feb 25 [cited 2025 Nov 27];17(3):131. Available from: https://www.mdpi.com/1422-0067/17/3/131/htm 33. Juste RA, Alonso-Hearn M, Garrido JM, Abendaño N, Sevilla IA, Gortazar C, et al. Increased Lytic Efficiency of Bovine Macrophages Trained with Killed Mycobacteria. Tyagi AK, editor. PLoS One [Internet]. 2016 Nov 7 [cited 2016 Nov 14];11(11):e0165607. Available from: http://dx.plos.org/10.1371/journal.pone.0165607 34. Yang SJ, Chen YY, Hsu CH, Hsu CW, Chang CY, Chang JR, et al. Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity. Front Immunol [Internet]. 2020 Jun 23 [cited 2022 Dec 21];11. Available from: https://pubmed.ncbi.nlm.nih.gov/32655570/ 35. Liu D, Wang J, Xu Z, Chen X, Jiao X. Phagocytosis: strategies for macrophages to hunt Mycobacterium tuberculosis. One Health Advances 2024 2:1 [Internet]. 2024 Dec 23 [cited 2025 Nov 27];2(1):32-. Available from: https://link.springer.com/article/10.1186/s44280024-00065-9 36. Blay-Benach M, Repullés J, Cuenca-Lara P, Pérez de Val B. Phagocytosis of Mycobacterium fortuitum by caprine alveolar macrophages is associated with iNOS and proinflammatory marker expression. In: 45th Annual Congress of the European Society of Mycobacteriology. Lisbon; 2025. p. 64–5. 37. Ochando J, Mulder WJM, Madsen JC, Netea MG, Duivenvoorden R. Trained immunity - basic concepts and contributions to immunopathology. Nat Rev Nephrol [Internet]. 2023 Jan 1 [cited 2025 Dec 2];19(1):23–37. Available from: https://pubmed.ncbi.nlm.nih.gov/36253509/ 38. Cohen SB, Gern BH, Urdahl KB. The Tuberculous Granuloma and Preexisting Immunity. Annu Rev Immunol [Internet]. 2022 Apr 26 [cited 2025 Dec 2];40(Volume 40, 2022):589– 614. Available from: https://www.annualreviews.org/content/journals/10.1146/annurevimmunol-093019-125148 39. Gideon HP, Hughes TK, Tzouanas CN, Wadsworth MH, Tu AA, Gierahn TM, et al. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity [Internet]. 2022 May 10 [cited 2025 Dec 2];55(5):827846.e10. Available from: https://www.sciencedirect.com/science/article/pii/S1074761322001753?via%3Dihub 40. Krueger G, Faisal S, Dorhoi A. Microenvironments of tuberculous granuloma: advances and opportunities for therapy. Front Immunol [Internet]. 2025 Mar 24;16:1575133. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1575133/fu ll 41. Kanipe C, Boggiatto PM, Putz EJ, Palmer M V. Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis. Front Microbiol [Internet]. 2022 Nov 8 [cited 2022 Nov 8];0:4495. Available from: https://www.frontiersin.org/articles/10.3389/fmicb.2022.1048648/full 42. Pérez De Val B, López-Soria S, Nofrarías M, Martín M, Vordermeier HM, VillarrealRamos B, et al. Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae. Clin Vaccine Immunol [Internet]. 2011;18(11). Available from: https://journals.asm.org/doi/10.1128/cvi.05323-11 43. Lin JR, Fallahi-Sichani M, Sorger PK. Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method. Nature Communications 2015 6:1 [Internet]. 2015 Sep 24 [cited 2025 Dec 2];6(1):8390-. Available from: https://www.nature.com/articles/ncomms9390 44. Domingo M, Vidal E, Marco A. Pathology of bovine tuberculosis. Res Vet Sci [Internet]. 2014 Oct;97:S20–9. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0034528814000927 45. McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB, et al. The immunoregulatory landscape of human tuberculosis granulomas. Nature Immunology 2022 23:2 [Internet]. 2022 Jan 20 [cited 2025 Dec 2];23(2):318–29. Available from: https://www.nature.com/articles/s41590-021-01121-x 46. Singh DK, Ahmed M, Akter S, Shivanna V, Bucşan AN, Mishra A, et al. Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate. Nature Communications 2025 16:1 [Internet]. 2025 Feb 25 [cited 2025 Dec 2];16(1):1957-. Available from: https://www.nature.com/articles/s41467-025-57090-4 47. Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS One [Internet]. 2013 Jan 15 [cited 2025 Dec 3];8(1). Available from: https://pubmed.ncbi.nlm.nih.gov/23308269/ 48. Guirado E, Mbawuike U, Keiser TL, Arcos J, Azad AK, Wang SH, et al. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. mBio [Internet]. 2015 Feb 17 [cited 2025 Dec 3];6(1). Available from: https://pubmed.ncbi.nlm.nih.gov/25691598/ 49. Arbués A, Kammüller M, Portevin D. Generating Three-dimensional Human Granulomas in vitro to Study Mycobacterium tuberculosis-Host Interaction. Bio Protoc [Internet]. 2020 [cited 2025 Nov 19];10(22):e3820. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7842406/ 50. Tezera LB, Bielecka MK, Chancellor A, Reichmann MT, Shammari B Al, Brace P, et al. Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3dimensional model. Elife [Internet]. 2017 Jan 7 [cited 2025 Dec 3];6. Available from: https://pubmed.ncbi.nlm.nih.gov/28063256/ 51. Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Front Microbiol [Internet]. 2018 Mar 29 [cited 2025 Dec 3];9. Available from: https://pubmed.ncbi.nlm.nih.gov/30425706/ 52. Stabel JR, Stabel TJ. Immortalization and characterization of bovine peritoneal macrophages transfected with SV40 plasmid DNA. Vet Immunol Immunopathol [Internet]. 1995 Apr 1 [cited 2025 Nov 21];45(3–4):211–20. Available from: https://www.sciencedirect.com/science/article/pii/016524279405348V?via%3Dihub 53. Garrido JM, Sevilla IA, Beltrán-Beck B, Minguijón E, Ballesteros C, Galindo RC, et al. Protection against tuberculosis in eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS One [Internet]. 2011;6(9). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024905 54. Balseiro A, Altuzarra R, Vidal E, Moll X, Espada Y, Sevilla IA, et al. Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep. PLoS One [Internet]. 2017;12(7). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180546 55. Olvera A, Ballester M, Nofrarias M, Sibila M, Aragon V. Differences in phagocytosis susceptibility in Haemophilus parasuis strains. Vet Res [Internet]. 2009 May [cited 2025 Dec 3];40(3). Available from: https://pubmed.ncbi.nlm.nih.gov/19239855/ 56. Wangoo A, Johnson L, Gough J, Ackbar R, Inglut S, Hicks D, et al. Advanced granulomatous lesions in Mycobacterium bovis-infected cattle are associated with increased expression of type I procollagen, gammadelta (WC1+) T cells and CD 68+ cells. J Comp Pathol [Internet]. 2005 Nov [cited 2022 Jul 12];133(4):223–34. Available from: https://pubmed.ncbi.nlm.nih.gov/16154140/ 57. Agulló-Ros I, Muñoz-Fernández L, Roy Á, Bezos J, Sevilla IA, Moreno I, et al. Protective effect of heat-inactivated Mycobacterium bovis applied intramuscularly is associated with enhanced lung immune response in caprine tuberculosis. Vet Res [Internet]. 2025 Nov 4 [cited 2025 Dec 4];56(1):209. Available from: https://pubmed.ncbi.nlm.nih.gov/41189022/ 58. Gil O, Díaz I, Vilaplana C, Tapia G, Díaz J, Fort M, et al. Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. Doherty TM, editor. PLoS One [Internet]. 2010 Apr 6 [cited 2019 Feb 21];5(4):e10030. Available from: http://dx.plos.org/10.1371/journal.pone.0010030 59. Domingo M, Gil O, Serrano E, Guirado E, Nofrarias M, Grassa M, et al. Effectiveness and Safety of a Treatment Regimen Based on Isoniazid Plus Vaccination with Mycobacterium tuberculosis cells’ Fragments: Field-Study with Naturally Mycobacterium caprae-Infected Goats. Scand J Immunol [Internet]. 2009; Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-3083.2009.02251.x 60. Vidal E, Arrieta-Villegas C, Grasa M, Mercader I, Domingo M, Pérez de Val B. Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats. BMC Vet Res [Internet]. 2017;13(1):252. Available from: https://link.springer.com/article/10.1186/s12917-017-1182-5 61. Pérez de Val B, Nofrarías M, López-Soria S, Garrido JM, Vordermeier HM, VillarrealRamos B, et al. Effects of vaccination against paratuberculosis on tuberculosis in goats: diagnostic interferences and cross-protection. BMC Vet Res [Internet]. 2012;8. Available from : https://link.springer.com/article/10.1186/1746-6148-8-191 62. Arrieta-Villegas C, Vidal E, Martín M, Verdés J, Moll X, Espada Y, et al. Immunogenicity and protection against mycobacterium caprae challenge in goats vaccinated with BCG and revaccinated after one year. Vaccines (Basel) [Internet]. 2020;8(4):1–16. Available from: https://www.mdpi.com/2076-393X/8/4/751 63. Arrieta-Villegas C, Infantes-Lorenzo JA, Bezos J, Grasa M, Vidal E, Mercader I, et al. Evaluation of P22 Antigenic Complex for the Immuno-Diagnosis of Tuberculosis in BCG Vaccinated and Unvaccinated Goats. Front Vet Sci [Internet]. 2020;7(July):1–9. Available from: https://www.frontiersin.org/journals/veterinaryscience/articles/10.3389/fvets.2020.00374/full 64. Wilkinson MD, Dumontier M, Aalbersberg IjJ, Appleton G, Axton M, Baak A, et al. The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 2016 3:1 [Internet]. 2016 Mar 15 [cited 2025 Dec 2];3(1):160018-. Available from: https://www.nature.com/articles/sdata201618